Selective Reductions in Plasma Aβ 1-42 in Healthy Elderly Subjects During Longitudinal Follow-Up: A Preliminary Report
Authors:
- 1 October 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 13 (10) , 914-917
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Plasma Aβ40 and Aβ42 and Alzheimer’s diseaseNeurology, 2003
- Cerebrospinal Fluid Beta-Amyloid 42 Is Reduced before the Onset of Sporadic Dementia: A Population-Based Study in 85-Year-OldsDementia and Geriatric Cognitive Disorders, 2003
- Amyloid β protein 1–40 and 1–42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer diseaseNeuroscience Letters, 2001
- Elevated plasma amyloid β-peptide 1–42 and onset of dementia in adults with Down syndromeNeuroscience Letters, 2001
- Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 2001
- Linkage of Plasma Aβ42 to a Quantitative Locus on Chromosome 10 in Late-Onset Alzheimer's Disease PedigreesScience, 2000
- Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer DiseaseArchives of Neurology, 2000
- Plasma amyloid ?-peptide 1-42 and incipient Alzheimer's diseaseAnnals of Neurology, 1999
- Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's diseaseNature Medicine, 1996
- Platelets Are the Primary Source of Amyloid β-Peptide in Human BloodBiochemical and Biophysical Research Communications, 1995